RACHEL FISHER: Open Payments
NPI 1285163071 · MARION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 46 payments from 10 companies in 2025. Trend: 2023 $607 · 2024 $683 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $332 |
| PFIZER INC. | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Novo Nordisk Inc | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: VRAYLAR, QULIPTA, Kerendia, UBRELVY, MOUNJARO, VIBERZI, FREESTYLE LIBRE 3, PREVNAR 20.
Industry payments across OH — which companies pay providers there.
